Circulating biomarkers for diagnosis, prognosis and treatment response prediction in cancer – Part A

Circulating biomarkers for diagnosis, prognosis and treatment response prediction in cancer – Part A, 1, 2025 is a comprehensive biology reference published by Elsevier. Description By Lorenzo Galluzzi, Sheila Spada Circulating Biomarkers for Diagnosis, Prognosis and Treatment Response Prediction in Cancer Patients, Part A, Volume 391 delves into the crucial role of circulating biomarkers in cancer diagnosis and treatment monitoring.

Key Features

- By Lorenzo Galluzzi, Sheila Spada
- Circulating Biomarkers for Diagnosis, Prognosis and Treatment Response Prediction in Cancer Patients, Part A, Volume 391 delves into the crucial role of circulating biomarkers in…
- Specific chapters in this new release include Circulating biomarkers for diagnosis and response to therapies in cancer patients, Identification of circulating tumor DNA as a…
- It covers cutting-edge research on circulating tumor cells, cell-free DNA, exosomes, and other biomarkers that can revolutionize cancer management
- Additionally, it discusses the challenges, advancements, and future prospects of utilizing circulating biomarkers in personalized cancer care
- Provides a comprehensive overview of circulating biomarkers used in cancer diagnosis, prognosis, and treatment response monitoring
- Discusses the clinical utility of circulating biomarkers in early cancer detection, prognostication, treatment selection, and monitoring therapeutic responses

Product Details

Publisher: Elsevier
Edition: 1
Published Year: 2025
Format: Publisher PDF
File Size: 8.6 MB
ISBN: 978-0443345296, 9780443345302